Oncotelic Therapeutics, Inc.

OTLC is the ticker symbol for Oncotelic Therapeutics, Inc., a publicly traded US company.

ONCOTELIC THERAPEUTCS INC

Key metrics include a return on equity of -0.8%, a debt-to-equity ratio of 0.50.

The company reports trailing twelve-month revenue of $70,000 and net loss of $2.19M.

FINOTAUR aggregates real-time and fundamental data on OTLC to help traders and investors make informed decisions. Track OTLC in your trading journal alongside other positions for a unified view of your portfolio.